POPS RICHARD F
SEC CIK 1126490 · EDGAR
BoughtSold
Most active insiders at NBIX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GORMAN KEVIN CHARLES | Dir | — | $37.82M |
| 2 | Cooke Julie | CHRO | — | $5.77M |
| 3 | Gano Kyle | CEO, Dir | — | $4.87M |
| 4 | Lippoldt Darin | CLO | — | $4.20M |
| 5 | SHERWIN STEPHEN A | Dir | — | $4.13M |
| 6 | Delaet Ingrid | Chief Regulatory Off | — | $3.75M |
| 7 | Onyia Jude | CSO | — | $3.47M |
| 8 | RASTETTER WILLIAM H | Dir | — | $2.73M |
| 9 | POPS RICHARD F | Dir | — | $2.36M |
| 10 | LYONS GARY A | Dir | — | $2.29M |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-21 19:23 | 2026-05-21 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | M - OptEx | $0.00 | +3,318 | 37.8K | +10% | $0 |
| DT | 2026-05-18 17:50 | 2026-05-15 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | M - OptEx | $47.89 | +15.0K | 49.5K | +44% | +$718.4K |
| DT | 2026-05-18 17:50 | 2026-05-15 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | S - Sale+OE | $157.65 | -15.0K | 34.5K | -30% | -$2.36M |
| 2026-02-06 | 2026-02-05 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | F - Tax | $33.55 | -62.2K | 1.38M | -4% | -$2.09M | |
| 2026-02-06 | 2026-02-05 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | A - Grant | — | +149.6K | 1.44M | +12% | — | |
| D | 2025-05-22 | 2025-05-22 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | M - OptEx | $0.00 | +2,869 | 34.5K | +9% | $0 |
| 2025-02-07 | 2025-02-06 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | F - Tax | $31.39 | -79.9K | 1.29M | -6% | -$2.51M | |
| 2025-02-07 | 2025-02-06 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | A - Grant | — | +190.6K | 1.37M | +16% | — | |
| D | 2024-05-21 | 2024-05-17 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | M - OptEx | $0.00 | +4,199 | 33.7K | +14% | $0 |
| D | 2024-05-21 | 2024-05-17 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | S - Sale+OE | $141.84 | -2,100 | 31.6K | -6% | -$297.9K |
| D | 2024-03-15 | 2024-03-13 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | M - OptEx | $42.76 | +23.2K | 52.7K | +79% | +$992.0K |
| D | 2024-03-15 | 2024-03-13 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | S - Sale+OE | $140.33 | -23.2K | 29.5K | -44% | -$3.26M |
| DM | 2024-03-12 | 2024-03-08+ | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | S - Sale+OE | $140.05 | -1,800 | 29.5K | -6% | -$252.1K |
| DM | 2024-03-12 | 2024-03-08+ | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | M - OptEx | $42.76 | +1,800 | 29.6K | +6% | +$77.0K |
| D | 2024-02-22 | 2024-02-20 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | S - Sale+OE | $132.47 | -15.0K | 29.5K | -34% | -$1.99M |
| D | 2024-02-22 | 2024-02-20 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | M - OptEx | $12.98 | +15.0K | 44.5K | +51% | +$194.7K |
| 2024-02-12 | 2024-02-08 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | A - Grant | — | +218.6K | 1.27M | +21% | — | |
| 2024-02-12 | 2024-02-08 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | F - Tax | $26.77 | -91.8K | 1.18M | -7% | -$2.46M | |
| D | 2023-02-22 | 2023-02-20 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | A - Grant | — | +119.7K | 1.09M | +12% | — |
| DM | 2023-02-22 | 2023-02-20+ | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | F - Tax | $28.01 | -67.5K | 1.05M | -6% | -$1.89M |
| D | 2023-02-22 | 2023-02-21 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | M - OptEx | — | +32.4K | 1.07M | +3% | — |
| D | 2023-01-05 | 2023-01-03 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | M - OptEx | $12.71 | +15.0K | 44.5K | +51% | +$190.7K |
| D | 2023-01-05 | 2023-01-03 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | S - Sale+OE | $119.20 | -15.0K | 29.5K | -34% | -$1.79M |
| DM | 2022-05-11 | 2022-05-09 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | M - OptEx | $6.66 | +15.0K | 37.0K | +68% | +$99.9K |
| DM | 2022-05-11 | 2022-05-09 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Dir | S - Sale+OE | $76.30 | -15.0K | 29.5K | -34% | -$1.14M |
| DM | 2022-05-06 | 2022-05-05+ | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | S - Sale+OE | $27.98 | -347.3K | 973.5K | -26% | -$9.72M |
| DM | 2022-05-06 | 2022-05-05+ | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | M - OptEx | $16.55 | +450.0K | 1.19M | +60% | +$7.45M |
| D | 2022-02-23 | 2022-02-21 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | F - Tax | $25.08 | -14.4K | 865.6K | -2% | -$360.8K |
| D | 2022-02-23 | 2022-02-21 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | M - OptEx | — | +32.4K | 879.9K | +4% | — |
| D | 2022-02-17 | 2022-02-16 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | F - Tax | $26.79 | -8,038 | 847.5K | -0.9% | -$215.3K |
| D | 2022-02-17 | 2022-02-16 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | M - OptEx | — | +18.1K | 855.6K | +2% | — |
| 2021-09-16 | 2021-09-14 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | F - Tax | $30.60 | -36.3K | 837.5K | -4% | -$1.11M | |
| 2021-09-16 | 2021-09-14 | ALKS | Alkermes plc. | POPS RICHARD F | CEO, Dir, Alkermes plc | A - Grant | $0.00 | +81.7K | 873.7K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations